Friday, June 19, 2026

biotech · Generalized Myasthenia Gravis · Leukemia, Myeloid, Acute · VOR

Vor Biopharma

News and analysis for Vor Biopharma on NovaPharmaNews — regulatory, clinical, and market coverage.

Cambridge, USA HQ
110 Employees
Public company Type
VOR · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Employees
110
Programs
6
Drugs
4
Patents
12
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Vor Biopharma — regulatory, clinical, and market coverage.

News and analysis for Vor Biopharma on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Vor Biopharma yet.

Back to company overview →